Table 2.
DSN | OST | FOA | ||||
---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | ||||
All participants n=840 |
484 (57.6) | 740 (88.1) | 486 (57.9) | |||
Age Category | ||||||
45-54 | 86 (36.1) | 188 (79.3) | 92 (38.5) | |||
55-64 | 153 (54.8) | 247 (88.5) | 146 (52.3) | |||
65-74 | 151 (73.3) | 193 (93.2) | 149 (72.3) | |||
75+ | 94 (80.3) | 112 (95.7) | 99 (85.3) | |||
Cross Tabulation | ||||||
DSN | N/A | 458 (54.5) | 327 (38.9) | |||
OST | N/A | N/A | 452 (53.8) | |||
DSN & OST | N/A | N/A | 313 (37.3) | |||
Women n=523 | 314 (60.4) | 0.068* | 462 (88.0) | 0.912* | 323 (61.6) | 0.004* |
Age Category | ||||||
45-54† | 48 (38.4) | 104 (83.2) | 59 (46.8) | |||
55-64 | 101 (54.0) | 163 (86.7) | 101 (53.7) | |||
65-74 | 97 (75.8) | 117 (90.7) | 92 (71.9) | |||
75+ | 68 (81.9) | 78 (94.0) | 71 (86.6) | |||
Men n=317 | 170 (53.6) | 278 (88.3) | 163 (51.6) | |||
Age Category | ||||||
45-54 | 38 (33.6) | 84 (75.0) | 33 (29.2) | |||
55-64 | 52 (56.5) | 84 (92.3) | 45 (49.5) | |||
65-74 | 54 (69.2) | 76 (97.4) | 57 (73.1) | |||
75+ | 26 (76.5) | 34 (100.0) | 28 (82.4) | |||
AAs n=316 | 165 (52.2) | 0.014* | 267 (84.5) | 0.012* | 142 (44.7) | <0.001* |
Age Category | ||||||
45-54 | 33 (30.6) | 80 (74.1) | 26 (23.9) | |||
55-64 | 61 (52.6) | 102 (87.9) | 51 (43.6) | |||
65-74 | 44 (68.8) | 59 (92.1) | 44 (68.8) | |||
75+ | 27 (96.4) | 26 (92.9) | 21 (75.0) | |||
Caucasians n=524 | 319 (60.9) | 473 (90.3) | 344 (65.9) | |||
Age Category | ||||||
45-54 | 53 (40.8) | 108 (83.7) | 66 (50.8) | |||
55-64 | 92 (56.4) | 145 (89.0) | 95 (58.6) | |||
65-74 | 107 (75.4) | 134 (93.7) | 105 (73.9) | |||
75+ | 67 (75.3) | 86 (96.6) | 78 (88.6) |
Disc space narrowing and vertebral osteophytes coded as mild or greater and facet joint osteoarthritis coded as absent or present.
p-value for difference in gender or race for each outcome.
Women <50 years old excluded (n=132). N/A= not applicable